IOL Tracking Requirements Are Cost-Prohibitive, Manufacturers Say
This article was originally published in The Gray Sheet
Executive Summary
Subjecting intraocular lenses to device tracking requirements is cost prohibitive given the Medicare payment limit for the device, lens manufacturers maintain in comments to FDA.